Cervical cancer

Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition

Volumn , Issue , 2017, Pages 925-946

  Herrero, Rolando ^a   Murillo, Raul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cervical cancer; Cervix; Etiology; HPV; Human papillomavirus; Oncogene; Risk

Indexed keywords

EID: 85051029965     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/oso/9780190238667.003.0048     Document Type: Chapter

References (219)

1. Abreu, AL, Souza, RP, Gimenes, F, Consolaro, ME. 2012. A review of methods for detect human Papillomavirus infection. Virol J, 9,262. PMCID: PMC3507852.
2. Adler, DH. 2010. The impact of HAART on HPV-related cervical disease. Curr HIV Res, 8(7), 493-497. PMCID: PMC3108243.
3. Almonte, M, Ferreccio, C, Luciani, S, et al. 2015. Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru. PLoS One, 10(1), e0115355. PMCID: PMC4312028.
4. ALTS Group. 2003. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol, 188(6), 1383-1392. PMID: 12824967.
5. Andersson-Ellstrom, A, Dillner, J, Hagmar, B, Schiller, J, Forssman, L. 1994. No serological evidence for non-sexual spread of HPV16. Lancet, 344(8934), 1435. PMID: 7968093.
6. Appleby, P, Beral, V, Berrington de, GA, et al. 2007. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet, 370(9599), 1609-1621.
7. Appleby, P, Beral, V, Berrington de, GA, et al. 2006. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 118(6), 1481-1495.
8. Arbyn, M, Anttila, A, Jordan, J, et al. 2010. European Guidelines for Quality Assurance in Cervical Cancer Screening-second edition-summary document. Ann Oncol, 21(3), 448-458.
9. Arbyn, M, Castellsague, X, de, SS, et al. 2011. Worldwide burden of cervical cancer in 2008. Ann Oncol, 22(12), 2675-2686. PMID: 21471563.
10. Arbyn, M, Ronco, G, Anttila, A, et al. 2012. Evidence regarding human pap-illomavirus testing in secondary prevention of cervical cancer. Vaccine, 30(Suppl 5), F88-F99. PMID: 23199969.
11. Arbyn, M, Tommasino, M, Depuydt, C, Dillner, J. 2014a. Are 20 human pap-illomavirus types causing cervical cancer? J Pathol, 234(4), 431-435. PMID: 25124771.
12. Arbyn, M, Verdoodt, F, Snijders, PJ, et al. 2014b. Accuracy of human papil-lomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol, 15(2), 172-183. PMID: 24433684.
13. Aubin, F, Martin, M, Puzenat, E, et al. 2011. Genital human Papillomavirus infection in patients with autoimmune inflammatory diseases. Joint Bone Spine, 78(5), 460-465. PMID: 21570889.
14. Blumenthal, PD, Gaffikin, L, Chirenje, ZM, McGrath, J, Womack, S, Shah, K. 2001. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet, 72(1), 47-53. PMID: 11146077.
15. Bosch, FX, Lorincz, A, Munoz, N, Meijer, CJ, Shah, KV. 2002. The causal rela-tion between human papillomavirus and cervical cancer. J Clin Pathol, 55(4), 244-265. PMCID: PMC1769629.
16. Bosch, FX, Robles, C, Diaz, M, et al. 2015. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat Rev Clin Oncol. PMID: 26323382.
17. Brotherton, JM, Fridman, M, May, CL, Chappell, G, Saville, AM, Gertig, DM. 2011. Early effect of the HPV vaccination programme on cervical abnor-malities in Victoria, Australia: an ecological study. Lancet, 377(9783), 2085-2092. PMID: 21684381.
18. Bruni, L, Diaz, M, Castellsague, X, Ferrer, E, Bosch, FX, de Sanjosé, S. 2010. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis, 202(12), 1789-1799. PMID: 21067372.
19. Burchell, AN, Richardson, H, Mahmud, SM, et al. 2006. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol, 163(6), 534-543. PMID: 16421235.
20. Burk, RD, Harari, A, Chen, Z. 2013. Human papillomavirus genome variants. Virology, 445(1-2), 232-243. PMCID: PMC3979972.
21. Canfell, K, Chesson, H, Kulasingam, SL, Berkhof, J, Diaz, M, Kim, JJ. 2012. Modeling preventative strategies against human papillomavirus- related disease in developed countries. Vaccine, 30 Suppl 5 F157-F167. PMCID: PMC3783354.
22. Castanon, A, Landy, R, Cuzick, J, Sasieni, P. 2014. Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study. PLoS Med, 11(1), e1001585. PMCID: PMC3891624.
23. Castellsague, X, Bosch, FX, Munoz, N, et al. 2002. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med, 346(15), 1105-1112. PMID: 11948269.
24. Castellsague, X, Diaz, M, de Sanjosé, S, et al. 2006. Worldwide human papillo-mavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, 98(5), 303-315. PMID: 16507827.
25. Castellsague, X, Diaz, M, Vaccarella, S, et al. 2011. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol, 12(11), 1023-1031. PMID: 21917519.
26. Castellsague, X, and Munoz, N. 2003. Chapter 3: Cofactors in human papil-lomavirus carcinogenesis: role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr, 31, 20-28. PMID: 12807941.
27. Castellsague, X, Naud, P, Chow, SN, et al. 2014a. Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA. J Infect Dis, 210(4), 517-534. PMCID: PMC4111909.
28. Castellsague, X, Pawlita, M, Roura, E, et al. 2014b. Prospective seroepidemio- logic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. Int J Cancer, 135(2), 440-452. PMID: 24338606.
29. Castle, PE, and Giuliano, AR. 2003. Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients: assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monogr, 31, 29-34. PMID: 12807942.
30. Castle, PE, Hillier, SL, Rabe, LK, et al. 2001. An association of cervical inflam-mation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev, 10(10), 1021-1027. PMID: 11588127.
31. CDC. 2013. Sexually transmitted disease surveillance 2012. Atlanta: Centers for Disease Control and Prevention, US Department of Health and Human Services.
32. Cerqueira, EM, Santoro, CL, Donozo, NF, et al. 1998. Genetic damage in exfo-liated cells of the uterine cervix. Association and interaction between cig-arette smoking and progression to malignant transformation? Acta Cytol, 42(3), 639-649. PMID: 9622681.
33. Chase, D, Goulder, A, Zenhausern, F, Monk, B, Herbst-Kralovetz, M. 2015. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol, 138(1), 190-200. PMID: 25957158.
34. Chen, C, Madeleine, MM, Weiss, NS, Daling, JR. 1999. Glutathione S- transferase M1 genotypes and the risk of vulvar cancer: a population-based case-control study. Am J Epidemiol, 150(5), 437-442. PMID: 10472942.
35. Chen, C, Yang, Z, Li, Z, Li, L. 2012. Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis. Int J Gynecol Cancer, 22(6), 908-921. PMID: 22672987.
36. Cheng, EM, Atkinson, PM, Shahani, AK. 2011. Elucidating the spatially varying relation between cervical cancer and socio-economic conditions in England. Int J Health Geogr, 1051. PMCID: PMC3305905.
37. Chih, HJ, Lee, AH, Colville, L, Binns, CW, Xu, D. 2013. A review of dietary prevention of human papillomavirus-related infection of the cervix and cervical intraepithelial neoplasia. Nutr Cancer, 65(3), 317-328. PMID: 23530631.
38. Cibula, D, Gompel, A, Mueck, AO, et al. 2010. Hormonal contraception and risk of cancer. Hum Reprod Update, 16(6), 631-650. PMID: 20543200.
39. Clarke, M, Schiffman, M, Wacholder, S, Rodriguez, AC, Hildesheim, A, Quint, W. 2013. A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. BMC Infect Dis, 13308. PMCID: PMC3723935.
40. Clifford, GM, Goncalves, MA, Franceschi, S. 2006. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS, 20(18), 2337-2344. PMID: 17117020.
41. Clifford, GM, Smith, JS, Plummer, M, Munoz, N, Franceschi, S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer, 88(1), 63-73. PMCID: PMC2376782.
42. Cogliano, V, Baan, R, Straif, K, Grosse, Y, Secretan, B, El, GF. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol, 6(4), 204. PMID: 15830458.
43. Cox, JT, Castle, PE, Behrens, CM, Sharma, A, Wright, TC, Jr., Cuzick, J. 2013. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol, 208(3), 184. PMID: 23174289.
44. Cubie, HA, and Cuschieri, K. 2013. Understanding HPV tests and their appro-priate applications. Cytopathology, 24(5), 289-308. PMID: 23998275.
45. Cuzick, J, Bergeron, C, von Knebel, DM, et al. 2012. New technologies and procedures for cervical cancer screening. Vaccine, 30 Suppl 5 F107-F116. PMID: 23199953.
46. Dai, M, Bao, YP, Li, N, et al. 2006. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer, 95(1), 96-101. PMCID: PMC2360486.
47. Darragh, TM, Colgan, TJ, Cox, JT, et al. 2012. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med, 136(10), 1266-1297. PMID: 22742517.
48. de Bekker-Grob, EW, de Kok, IM, Bulten, J, et al. 2012. Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis. Cancer Causes Control, 23(8), 1323-1331. PMID: 22706692.
49. de Freitas, AC, Gurgel, AP, Chagas, BS, Coimbra, EC, do Amaral, CM. 2012. Susceptibility to cervical cancer: an overview. Gynecol Oncol, 126(2), 304-311. PMID: 22484226.
50. de Sanjose, S, Quint, WG, Alemany, L et al. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11(11), 1048-1056. PMID: 20952254.
51. de Villiers, EM. 2003. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer, 103(6), 705-708. PMCID: PMC12516087.
52. Deacon, JM, Evans, CD, Yule, R, et al. 2000. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer, 83(11), 1565-1572. PMCID: PMC2363425.
53. Denny, L, Kuhn, L, Pollack, A, Wainwright, H, Wright, TC, Jr. 2000. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer, 89(4), 826-833. PMID: 10951346.
54. Denny, L, Quinn, M, Sankaranarayanan, R. 2006. Chapter 8: Screening for cervical cancer in developing countries. Vaccine, 24 (Suppl 3), S3/71-S3/77. PMID: 16950020.
55. Denslow, SA, Rositch, AF, Firnhaber, C, Ting, J, Smith, JS. 2014. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS, 25(3), 163-177. PMID: 24216030.
56. Dillner, J. 2013. Primary human papillomavirus testing in organized cervical screening. Curr Opin Obstet Gynecol, 25(1), 11-16. PMID: 23299089.
57. Drolet, M, Benard, E, Boily, MC, et al. 2015. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis, 15(5), 565-580. PMID: 25744474.
58. Dugue, PA, Rebolj, M, Garred, P, Lynge, E. 2013. Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther, 13(1), 29-42. PMID: 23259425.
59. Einstein, MH, Smith, KM, Davis, TE, et al. 2014. Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy. J Clin Microbiol, 52(6), 2089-2095. PMCID: PMC4042758.
60. Ferris, DG, and Greenberg, MD. 1994. Reid's Colposcopic Index. J Fam Pract, 39(1), 65-70. PMID: 7517993.
61. Forouzanfar, MH, Foreman, KJ, Delossantos, AM, et al. 2011. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet, 378(9801), 1461-1484. PMID: 21924486.
62. Franceschi, S, Herrero, R, Clifford, GM, et al. 2006. Variations in the age- specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer, 119(11), 2677-2684. PMID: 16991121.
63. Franco, EL. 2000. Statistical issues in human papillomavirus testing and screening. Clin Lab Med, 20(2), 345-367. PMID: 10863644.
64. Franco, EL, Mahmud, SM, Tota, J, Ferenczy, A, Coutlee, F. 2009. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change. Arch Med Res, 40(6), 478-485. PMID: 19853188.
65. Gadducci, A, Barsotti, C, Cosio, S, Domenici, L, Riccardo, GA. 2011. Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol, 27(8), 597-604. PMID: 21438669.
66. Gamboa, O, and Murillo, R. 2016. Estimacion de la carga economica de las lesiones preneoplasicas y el cancer de cuello uterino en Colombia. Implicaciones para la vacunacion contra el VPH. Revista Colombiana de Cancerologia, 20(2): 61-72.
67. Garcia-Closas, R, Castellsague, X, Bosch, X, Gonzalez, CA. 2005. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer, 117(4), 629-637. PMID: 15912536.
68. Ghittoni, R, Accardi, R, Chiocca, S, Tommasino, M. 2015. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience, 9526. PMCID: PMC4431404.
69. Gierisch, JM, Coeytaux, RR, Urrutia, RP, et al. 2013. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev, 22(11), 1931-1943. PMID: 24014598.
70. Giorgi-Rossi, P, Franceschi, S, Ronco, G. 2012. HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int J Cancer, 130(6), 1387-1394. PMID: 21520039.
71. Goldie, SJ, Gaffikin, L, Goldhaber-Fiebert, JD, et al. 2005. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med, 353(20), 2158-2168. PMID: 16291985.
72. Gonzalez, P, Hildesheim, A, Rodriguez, AC, et al. 2010. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev, 19(12), 3044-3054. PMCID: PMC3703390.
73. Goodman, MT, Shvetsov, YB, McDuffie, K, et al. 2007. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res, 67(12), 5987-5996. PMID: 17553901.
74. Guan, P, Howell-Jones, R, Li, N, et al. 2012. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer, 131(10), 2349-2359. PMID: 22323075.
75. Gustafsson, L, Ponten, J, Zack, M, Adami, HO. 1997. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control, 8(5), 755-763. PMID: 9328198.
76. Harris, TG, Kulasingam, SL, Kiviat, NB, et al. 2004. Cigarette smoking, onco-genic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol, 159(9), 834-842. PMID: 15105176.
77. Hemminki, K, Jiang, Y, Dong, C. 2001. Second primary cancers after anogenital, skin, oral, esophageal and rectal cancers: etiological links? Int J Cancer, 93(2), 294-298. PMID: 11410880.
78. Herbert, A, Breen, C, Bryant, TN, et al. 1996. Invasive cervical cancer in Southampton and South West Hampshire: effect of introducing a comprehensive screening programme. J Med Screen, 3(1), 23-28. PMID: 8861047.
79. Hercberg, S, Czernichow, S, Galan, P. 2006. Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study. Br J Nutr, 96 Suppl 1 S28-S30. PMID: 16923246.
80. Herfs, M, Yamamoto, Y, Laury, A, et al. 2012. A discrete population of squamo- columnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A, 109(26), 10516-10521. PMCID: PMC3387104.
81. Herrero, R, Brinton, LA, Reeves, WC, et al. 1989. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst, 81(3), 205-211. PMID: 2536087.
82. Herrero, R, Gonzalez, P, Markowitz, LE. 2015. Present status of human papillo-mavirus vaccine development and implementation. Lancet Oncol, 16(5), e206-e216. PMID: 25943065.
83. Hildesheim, A, Herrero, R, Castle, PE, et al. 2001. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer, 84(9), 1219-1226. PMCID: PMC2363883.'
84. Hoda, RS, Loukeris, K, Abdul-Karim, FW. 2013. Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences. Diagn Cytopathol, 41(3), 257-278. PMID: 22508662.
85. IARC. 2007. A review of human carcinogens. B. Biological agents. IARC Monogr Eval Carcinog Risks Hum, 100 (Pt B), 255-313.
86. Iftner, T, Becker, S, Neis, KJ, et al. 2015. Head-t o-head comparison of the RNA-based Aptima Human Papillomavirus (HPV) assay and the DNA- based Hybrid Capture 2 HPV Test in a routine screening population of women aged 30 to 60 years in Germany. J Clin Microbiol, 53(8), 2509-2516. PMCID: PMC4508437.
87. International Collaboration of Epidemiological Studies of Cervical Cancer. 2007. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer, 120(4), 885-891. PMID: 17131323.
88. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby, P, Beral, V, et al. 2007. Cervical cancer and hormonal contracep-tives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epi-demiological studies. Lancet, 370(9599), 1609-1621. PMID: 17993361.
89. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby, P, Berrington de Gonzalez, A, et al. 2006. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer, 118(6), 1481-1495. PMID: 16206285.
90. Jensen, KE, Schmiedel, S, Frederiksen, K, Norrild, B, Iftner, T, Kjaer, SK. 2012. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev, 21(11), 1949-1955. PMCID: PMC3970163.
91. Jensen, KE, Schmiedel, S, Norrild, B, Frederiksen, K, Iftner, T, Kjaer, SK. 2013. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer, 108(1), 234-239. PMCID: PMC3553518.
92. Jensen, KE, Thomsen, LT, Schmiedel, S, et al. 2014. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect, 90(7), 550-555. PMID: 24728044.
93. Jeronimo, J, Bansil, P, Lim, J, et al. 2014. A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. Int J Gynecol Cancer, 24(3), 576-585. PMCID: PMC4047307.
94. Jiang, J, Pang, H, Liu, B, et al. 2015. Effects of active, passive, and combined smoking on cervical cancer mortality: a nationwide proportional mortality study in Chinese urban women. Cancer Causes Control, 26(7), 983-991. PMID: 25898822.
95. Jin, AZ, Louange, EC, Chow, KY, Fock, CW. 2013. Evaluation of the National Cervical Cancer Screening Programme in Singapore. Singapore Med J, 54(2), 96-101. PMID: 23462834.
96. Kadhel, P, Multigner, L, Bardinet, F, Goerger-Sow, M, Janky, E. 2012. Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies. HIV Med, 13(1), 79-82. PMID: 21819528.
97. Kahn, JA, Brown, DR, Ding, L et al. 2012. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics, 130(2), e249-e256. PMCID: PMC3408690.
98. Kavanagh, K, Sinka, K, Cuschieri, K, et al. 2013. Estimation of HPV prevalence in young women in Scotland: monitoring of future vaccine impact. BMC Infect Dis, 13519. PMCID: PMC4228358.
99. Keller, MJ, Burk, RD, Xie, X, et al. 2012. Risk of cervical precancer and cancer among HIV-i nfected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA, 308(4), 362-369. PMCID: PMC3556987.
100. Khan, MJ, Partridge, EE, Wang, SS, Schiffman, M. 2005. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer, 104(1), 61-70. PMID: 15889450.
101. Kitchener, HC, Castle, PE, Cox, JT. 2006. Chapter 7: Achievements and limita-tions of cervical cytology screening. Vaccine, 24 (Suppl 3), S3/63-S3/70. PMID: 16950019.
102. Kleinerman, R., Kosary, C., Hildesheim, A. (2006). New malignancies following cancer of the cervix uteri, vagina, and vulva. In New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000 (pp. 207-229). Bethesda, MD: National Cancer Institute.
103. Ko, YJ, Kim, S, Kim, KH, Lee, K, Lee, CM. 2015. Cancer screening adherence of Asian women according to biochemically-verified smoking status: Korea National Health and Nutrition Examination Survey. Asian Pac J Cancer Prev, 16(9), 4081-088. PMID: 25987091.
104. Koliopoulos, G, Arbyn, M, Martin-Hirsch, P, Kyrgiou, M, Prendiville, W, Paraskevaidis, E. 2007. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and metaanalysis of non-tandomized studies. Gynecol Oncol, 104(1), 232-246. PMID: 17084886.
105. Koss, LG. 1989. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA, 261(5), 737-743. PMID: 2642983.
106. Kruger-Kjaer, S, Van Den Brule, AJ, Svare, EI, et al. 1998. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer, 76(5), 613-619. PMID: 9610715.
107. Kurdgelashvili, G, Dores, GM, Srour, SA, Chaturvedi, AK, Huycke, MM, Devesa, SS. 2013. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Cancer, 119(12), 2291-2299. PMCID: PMC4567689.
108. La Vecchia, C, and Boccia, S. 2014. Oral contraceptives, human papillomavirus and cervical cancer. Eur J Cancer Prev, 23(2), 110-112. PMID: 24469243.
109. La Vecchia, C, Franceschi, S, Decarli, A, Fasoli, M, Gentile, A, Tognoni, G. 1986. Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol, 123(1), 22-29. PMID: 3940440.
110. Lacey, JV, Jr., Brinton, LA, Barnes, WA, et al. 2000. Use of hormone replace-ment therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol, 77(1), 149-154. PMID: 10739704.
111. Lacey, JV, Swanson, CA, Brinton, LA et al. 2003. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer, 98(4), 814-821. PMID: 12910527.
112. Lam, JU, Rebolj, M, Dugue, PA, Bonde, J, von Euler-Chelpin, M, Lynge, E. 2014. Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies. J Med Screen, 21(1), 38-50. PMID: 24488594.
113. Lazcano-Ponce, E, Herrero, R, Munoz, N, et al. 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer, 91(3), 412-420. PMID: 11169968.
114. Legood, R, Wolstenholme, J, Gray, A. 2009. From cost-effectiveness information to decision-making on liquid-based cytology: mind the gap. Health Policy, 89(2), 193-200. PMID: 18619702.
115. Li, N, Franceschi, S, Howell-Jones, R, Snijders, PJ, Clifford, GM. 2011. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer, 128(4), 927-935. PMID: 20473886.
116. Liao, SF, Lee, WC, Chen, HC, Chuang, LC, Pan, MH, Chen, CJ. 2012. Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years. Cancer Causes Control, 23(5), 703-708. PMID: 22450735.
117. Lin, SJ. 2008. Factors influencing the uptake of screening services for breast and cervical cancer in Taiwan. J R Soc Promot Health, 128(6), 327-334. PMID: 19058475.
118. Louie, KS, Castellsague, X, de, SS, et al. 2011. Smoking and passive smoking in cervical cancer risk: pooled analysis of couples from the IARC multi- centric case-control studies. Cancer Epidemiol Biomarkers Prev, 20(7), 1379-1390. PMID: 21610224.
119. Ma, Y, Madupu, R, Karaoz, U, et al. 2014. Human papillomavirus community in healthy persons, defined by metagenomics analysis of human micro- biome project shotgun sequencing data sets. J Virol, 88(9), 4786-797. PMCID: PMC3993818.
120. Mandelblatt, J. 1993. Squamous cell cancer of the cervix, immune senescence and HPV: is cervical cancer an age-related neoplasm? Adv Exp Med Biol, 33013-26. PMID: 8396309.
121. Manhart, LE, and Koutsky, LA. 2002. Do condoms prevent genital HPV infec-tion, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis, 29(11), 725-735. PMID: 12438912.
122. Marks, M, Gravitt, PE, Gupta, SB, et al. 2011. Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. J Infect Dis, 204(10), 1505-1513. PMCID: PMC3222104.
123. Massad, LS, Seaberg, EC, Watts, DH, et al. 2009. Long-rerm incidence of cervical cancer in women with human immunodeficiency virus. Cancer, 115(3), 524-530. PMCID: PMC2641995.
124. Matsumoto, K, Oki, A, Furuta, R, et al. 2010. Tobacco smoking and regression of low-grade cervical abnormalities. Cancer Sci, 101(9), 2065-2073. PMID: 20626752.
125. Mayrand, MH, Duarte-Franco, E, Rodrigues, I, et al. 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med, 357(16), 1579-1588. PMID: 17942871.
126. Mbulaiteye, SM, Katabira, ET, Wabinga, H, et al. 2006. Spectrum of cancers among HIV-i nfected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer, 118(4), 985-990. PMID: 16106415.
127. McCann, MF, Irwin, DE, Walton, LA, Hulka, BS, Morton, JL, Axelrad, CM. 1992. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev, 1(2), 125-129. PMID: 1306094.
128. McCredie, MR, Sharples, KJ, Paul, C, et al. 2008. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithe- lial neoplasia 3: a retrospective cohort study. Lancet Oncol, 9(5), 425-434. PMID: 18407790.
129. McIntyre-Seltman, K, Castle, PE, Guido, R, Schiffman, M, Wheeler, CM. 2005. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev, 14(5), 1165-1170. PMID: 15894667.
130. McKenzie, ND, Kobetz, EN, Hnatyszyn, J, Twiggs, LB, Lucci, JA, III. 2010. Women with HIV are more commonly infected with non-16 and -18 high- risk HPV types. Gynecol Oncol, 116(3), 572-577. PMID: 19906410.
131. Mehlhorn, G, Kage, A, Munzenmayer, C et al. 2012. Computer-assisted diagnosis (CAD) in colposcopy: evaluation of a pilot study. Anticancer Res, 32(12), 5221-5226. PMID: 23225419.
132. Mirkovic, J, Howitt, BE, Roncarati, P, et al. 2015. Carcinogenic HPV infection in the cervical squamo-columnar junction. J Pathol, 236(3), 265-271. PMCID: PMC4457596.
133. Munoz, N, Bosch, FX, de Sanjosé, S, et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348(6), 518-527. PMID: 12571259.
134. Munoz, N, Franceschi, S, Bosetti, C, et al. 2002. Role of parity and human pap-illomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 359(9312), 1093-1101. PMID: 11943256.
135. Munoz, N, Kjaer, SK, Sigurdsson, K, et al. 2010. Impact of human papilloma-virus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst, 102(5), 325-339. PMID: 20139221.
136. Murillo, R, Almonte, M, Pereira, A, et al. 2008. Cervical cancer screening pro-grams in Latin America and the Caribbean. Vaccine, 26 (Suppl 11), L37-L48. PMID: 18945401.
137. Neale, RE, Darlington, S, Murphy, MF, Silcocks, PB, Purdie, DM, Talback, M. 2005. The effects of twins, parity and age at first birth on cancer risk in Swedish women. Twin Res Hum Genet, 8(2), 156-162. PMID: 15901479.
138. Nobbenhuis, MA, Walboomers, JM, Helmerhorst, TJ, et al. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet, 354(9172), 20 PMID: 10406360.
139. Oakeshott, P, Aghaizu, A, Reid, F, et al. 2012. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ, 344e4168. PMCID: PMC3382227.
140. Olsen, AO, Dillner, J, Skrondal, A, Magnus, P. 1998. Combined effect of smok-ing and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology, 9(3), 346-349. PMID: 9583429.
141. Palefsky, JM. 2003. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol, 15(5), 382-388. PMID: 12960521.
142. Palefsky, JM, Minkoff, H, Kalish, LA et al. 1999. Cervicovaginal human papil-lomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst, 91(3), 226-236. PMID: 10037100.
143. Parikh, S, Brennan, P, Boffetta, P. 2003. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer, 105(5), 687-691. PMID: 12740919.
144. Parkin, DM, Almonte, M, Bruni, L, Clifford, G, Curado, MP, Pineros, M. 2008. Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine, 26 (Suppl 11), L1-L15. PMID: 18945399.
145. Parkin, DM, and Bray, F. 2006. Chapter 2: The burden of HPV-related cancers. Vaccine, 24(Suppl 3), S3/11-S3/25.
146. Peto, J, Gilham, C, Fletcher, O, Matthews, FE. 2004. The cervical cancer epi-demic that screening has prevented in the UK. Lancet, 364(9430), 249-256. PMID: 15262102.
147. Pett, M, and Coleman, N. 2007. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol, 212(4), 356-367. PMID: 17573670.
148. Pierce, MC, Guan, Y, Quinn, MK, et al. 2012. A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer. Cancer Prev Res (Phila), 5(11), 1273-1279. PMCID: PMC3494281.
149. Pirog, EC, Lloveras, B, Molijn, A, et al. 2014. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol, 27(12), 1559-1567. PMID: 24762548.
150. Plummer, M, Peto, J, Franceschi, S. 2012. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer, 130(11), 2638-2644. PMCID: PMC3982220.
151. Plummer, M, Schiffman, M, Castle, PE, Maucort-Boulch, D, Wheeler, CM. 2007. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis, 195(11), 1582-1589. PMID: 17471427.
152. Porras, C, Rodriguez, AC, Hildesheim, A, et al. 2009. Human papillomavirus types by age in cervical cancer precursors: predominance of human pap-illomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev, 18(3), 863-865. PMCID: PMC2772192.
153. Pretorius, RG, Belinson, JL, Burchette, RJ, Hu, S, Zhang, X, Qiao, YL. 2011. Regardless of skill, performing more biopsies increases the sensitivity of colposcopy. J Low Genit Tract Dis, 15(3), 180-188. PMID: 21436729.
154. Prokopczyk, B, Cox, JE, Hoffmann, D, Waggoner, SE. 1997. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and non-smokers. J Natl Cancer Inst, 89(12), 868-873. PMID: 9196253.
155. Prokopczyk, B, Sinha, I, Trushin, N, Freeman, WM, El-Bayoumy, K. 2009. Gene expression profiles in HPV-immortalized human cervical cells treated with the nicotine-derived carcinogen 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone. Chem Biol Interact, 177(3), 173-180. PMCID: PMC2723790.
156. Pukkala, E, Martinsen, JI, Lynge, E, et al. 2009. Occupation and cancer: follow- up of 15 million people in five Nordic countries. Acta Oncol, 48(5), 646-790. PMID: 19925375.
157. Qiao, YL, Sellors, JW, Eder, PS, et al. 2008. A new HPV-DNA test for cervical- cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol, 9(10), 929-936. PMID: 18805733.
158. Quinn, M, Babb, P, Jones, J, Allen, E. 1999. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ, 318(7188), 904-908. PMCID: PMC27810.
159. Racey, CS, Withrow, DR, Gesink, D. 2013. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health, 104(2), e159-e166. PMID: 23618210.
160. Rakowski, W, Clark, MA, Ehrich, B. 1999. Smoking and cancer screening for women ages 42-75: associations in the 1990-1994 National Health Interview Surveys. Prev Med, 29(6 Pt 1), 487-95. PMID: 10600429.
161. Robboy, SJ, Noller, KL, O'Brien, P, et al. 1984. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA, 252(21), 2979-2983. PMID: 6502858.
162. Rodriguez, AC, Schiffman, M, Herrero, R, et al. 2008. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst, 100(7), 513-517. PMCID: PMC3705579.
163. Rositch, AF, Koshiol, J, Hudgens, MG et al. 2013. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer, 133(6), 1271-1285. PMCID: PMC3707974.
164. Roura, E, Castellsague, X, Pawlita, M, et al. 2014. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer, 135(2), 453-466. PMID: 24338632.
165. Russomano, F, Reis, A, Camargo, MJ, Grins ztejn, B, Tristao, MA. 2008. Recurrence of cervical intraepithelial neoplasia grades 2 or 3 in HIV- infected women treated by large loop excision of the transformation zone (LLETZ). Sao Paulo Med J, 126(1), 17-22. PMID: 18425282.
166. Safaeian, M, Porras, C, Schiffman, M, et al. 2010a. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infec-tions. J Natl Cancer Inst, 102(21), 1653-1662. PMCID: PMC2970577.
167. Safaeian, M, Quint, K, Schiffman, M, et al. 2010b. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst, 102(23), 1794-1804. PMCID: PMC2994864.
168. Samir, R, Asplund, A, Tot, T, Pekar, G, Hellberg, D. 2012. Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia. Contraception, 85(3), 288-293. PMID: 22067748.
169. Samoff, E, Koumans, EH, Markowitz, LE, et al. 2005. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol, 162(7), 668-675. PMID: 16120706.
170. Sankaranarayanan, R, Esmy, PO, Rajkumar, R, et al. 2007. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet, 370(9585), 398-406. PMID: 17679017.
171. Sankaranarayanan, R, Wesley, R, Thara, S, et al. 2003. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer, 106(3), 404-08. PMID: 12845681.
172. Santana, IU, Gomes, AN, Lyrio, LD, Rios Grassi, MF, Santiago, MB. 2011. Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review. Clin Rheumatol, 30(5), 665-672. PMID: 21072553.
173. Saraiya, M, Steben, M, Watson, M, Markowitz, L. 2013. Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Prev Med, 57(5), 426-433. PMCID: PMC4515308.
174. Sasieni, P. 2007. Cervical cancer prevention and hormonal contraception. Lancet, 370(9599), 1591-1592. PMID: 17993345.
175. Sasieni, P, Castanon, A, Cuzick, J. 2009. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ, 339b2968. PMCID: PMC2718082.
176. Schiffman, M, Glass, AG, Wentzensen, N, et al. 2011. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev, 20(7), 1398-1409. PMCID: PMC3156084.
177. Schiffman, MH, and Hildesheim, A. 2006. Cervical cancer. In: Schottenfeld D and Fraumeni JF, Jr. (Eds.), Cancer Epidemiology and Prevention (3rd ed., pp. 1044-1067). Oxford University Press, New York.
178. Schiffman, MH, and Schatzkin, A. 1994. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res, 54(7 Suppl), 1944s-1947s. PMID: 7794294.
179. Schiller, JT, and Davies, P. 2004. Delivering on the promise: HPV vaccines and cervical cancer. Nat Rev Microbiol, 2(4), 343-347. PMID: 15031733.
180. Shi, R, Devarakonda, S, Liu, L, Taylor, H, Mills, G. 2014. Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007-2010. BMC Res Notes, 7544. PMCID: PMC4141114.
181. Siegel, EM, Patel, N, Lu, B, et al. 2012a. Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? Int J Cancer, 131(1), 219-228. PMCID: PMC3319468.
182. Siegel, EM, Patel, N, Lu, B, et al. 2012b. Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection. Cancer Epidemiol Biomarkers Prev, 21(5), 859-865. PMCID: PMC3709556.
183. Siegel, EM, Salemi, JL, Villa, LL, Ferenczy, A, Franco, EL, Giuliano, AR. 2010. Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecol Oncol, 118(3), 289-294. PMCID: PMC3691953.
184. Singh, DK, Anastos, K, Hoover, DR, et al. 2009. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis, 199(12), 1851-1861. PMCID: PMC2814215.
185. Singh, GK, Williams, SD, Siahpush, M, Mulhollen, A. 2011. Socioeconomic, rural-urban, and racial inequalities in US Cancer Mortality: Part I: All can-cers and lung cancer and Part II: Colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol, 2011, 107497, 27. PMCID: PMC3307012.
186. Smith, JS, Bosetti, C, Munoz, N, et al. 2004. Chlamydia trachomatis and inva-sive cervical cancer: a pooled analysis of the IARC multicentric case- control study. Int J Cancer, 111(3), 431-439. PMID: 15221973.
187. Soerjomataram, I, Lortet-Tieulent, J, Parkin, DM, et al. 2012. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 380(9856), 1840-1850. PMID: 23079588.
188. Solomon, D, Davey, D, Kurman, R, et al. 2002. The 2001 Bethesda System: ter-minology for reporting results of cervical cytology. JAMA, 287(16), 2114-2119. PMID: 11966386.
189. Stanley, M, Pinto, LA, Trimble, C. 2012. Human papillomavirus vaccines-- immune responses. Vaccine, 30 (Suppl 5), F83-F87. PMID: 23199968.
190. Stern, PL, van der Burg, SH, Hampson, IN, et al. 2012. Therapy of human papillomavirus-related disease. Vaccine, 30 (Suppl 5), F71-F82. PMCID: PMC4155500.
191. Stoler, MH, Vichnin, MD, Ferenczy, A, et al. 2011. The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials. Int J Cancer, 128(6), 1354-1362. PMID: 20506504.
192. Sun, XW, Kuhn, L, Ellerbrock, TV, Chiasson, MA, Bush, TJ, Wright, TC, Jr. 1997. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med, 337(19), 1343-1349. PMID: 9358128.
193. Szarewski, A, Jarvis, MJ, Sasieni, P, et al. 1996. Effect of smoking cessation on cervical lesion size. Lancet, 347(9006), 941-943. PMID: 8598759.
194. Tabrizi, SN, Brotherton, JM, Kaldor, JM, et al. 2014. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis, 14(10), 958-966. PMID: 25107680.
195. Thulaseedharan, JV, Malila, N, Hakama, M, et al. 2013. Effect of screening on the risk estimates of socio demographic factors on cervical cancer: a large cohort study from rural India. Asian Pac J Cancer Prev, 14(1), 589-594. PMID: 23534800.
196. Trimble, CL, Genkinger, JM, Burke, AE, et al. 2005. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol, 105(1), 174-181. PMCID: PMC3064987.
197. Trimble, CL, Morrow, MP, Kraynyak, KA, et al. 2015. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine tar-geting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet, 386(10008), 2078-2088. PMID: 26386540.
198. Tsai, RJ, Luckhaupt, SE, Sweeney, MH, Calvert, GM. 2014. Shift work and cancer screening: do females who work alternative shifts undergo recommended cancer screening? Am J Ind Med, 57(3), 265-275. PMCID: PMC4557694.
199. Vaccarella, S, Franceschi, S, Engholm, G, Lonnberg, S, Khan, S, Bray, F. 2014. 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence. Br J Cancer, 111(5), 965-969. PMCID: PMC4150271.
200. Vaccarella, S, Franceschi, S, Herrero, R, et al. 2006. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev, 15(2), 326-333. PMID: 16492924.
201. Vakilian, K, Ranjbar, A, Zarganjfard, A, et al. 2009. On the relation of oxidative stress in delivery mode in pregnant women; a toxicological concern. Toxicol Mech Methods, 19(2), 94-99. PMID: 19778252.
202. Valerianova, Z, Panayotova, Y, Amati, C, Baili, P. 2010. Cervical cancer screen-ing in Bulgaria-- past and present experience. Tumori, 96(4), 538-544. PMID: 20968132.
203. Wacholder, S. 2003. Chapter 18: Statistical issues in the design and analysis of studies of human papillomavirus and cervical neoplasia. J Natl Cancer Inst Monogr, 31, 125-130. PMID: 12807956.
204. Walboomers, JM, Jacobs, MV, Manos, MM, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189(1), 12-19. PMID: 10451482.
205. Weiderpass, E, Pukkala, E, Vasama-Neuvonen, K, et al. 2001. Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med, 39(6), 572-580. PMID: 11385641.
206. Wentzensen, N, and Klug, SJ. 2009. Cervical cancer control in the era of HPV vaccination and novel biomarkers. Pathobiology, 76(2), 82-89. PMCID: 19367128.
207. Wentzensen, N, Walker, JL, Gold, MA, et al. 2015. Multiple biopsies and detec-tion of cervical cancer precursors at colposcopy. J Clin Oncol, 33(1), 8389. PMCID: PMC4268255.
208. White, EA, Sowa, ME, Tan, MJ, et al. 2012. Systematic identification of inter-actions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc Natl Acad Sci U S A, 109(5), E260-E267. PMCID: PMC3277141.
209. Whitlock, EP, Vesco, KK, Eder, M, Lin, JS, Senger, CA, Burda, BU. 2011. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 155(10), 687-5. PMID: 22006930.
210. WHO. 2013. WHO guidelines for screening and treatment of precancer- ous lesions for cervical cancer prevention. Geneva: World Health Organization. http://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en
211. WHO. 2014. Mortality database. (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/) Accessed January 13, 2017.
212. WHO. December 17, 2015. Global Advisory Committee on Vaccine Safety: Statement on safety of HPV vaccines. Geneva, Switzerland. http://www.who. int/vaccine_safety/committee/GACVS_HPV_statement_17Dec2015.pdf.
213. Williams, VM, Filippova, M, Soto, U, Duerksen-Hughes, PJ. 2011. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol, 6(1), 45-57. PMCID: PMC3037184.
214. Winkelstein, W, Jr., Sacks, ST, Ernster, VL, Selvin, S. 1977. Correlations of incidence rates for selected cancers in the nine areas of the Third National Cancer Survey. Am J Epidemiol, 105(5), 407-419. PMID: 871117.
215. Wright, TC, Jr., Cox, JT, Massad, LS, Carlson, J, Twiggs, LB, Wilkinson, EJ. 2003. 2001 consensus guidelines for the management of women with cer-vical intraepithelial neoplasia. Am J Obstet Gynecol, 189(1), 295-304. PMID: 12861176.
216. Wright, TC, Jr., Cox, JT, Massad, LS, Twiggs, LB, Wilkinson, EJ. 2002. 2001 Consensus Guidelines for the management of women with cervical cyto- logical abnormalities. JAMA, 287(16), 2120-2129. PMID: 11966387.
217. Zeng, XT, Xiong, PA, Wang, F, Li, CY, Yao, J, Guo, Y. 2012. Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pac J Cancer Prev, 13(6), 2687-2693. PMID: 22938442.
218. Zhang, X, Zhang, L, Tian, C, Yang, L, Wang, Z. 2014. Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review. BJOG, 121(6), 664-674. PMID: 24548744.
219. Zhao, FH, Jeronimo, J, Qiao, YL, et al. 2013. An evaluation of novel, lower- cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila), 6(9), 938-948